Analyse coût efficacité And NotTeresa M. Waters
List of bibliographic references
Number of relevant bibliographic references: 7.| Ident. | Authors (with country if any) | Title |
|---|---|---|
| 000695 | Tom L. Drake [Royaume-Uni] ; Zaid Chalabi [Royaume-Uni] ; Richard Coker [Royaume-Uni] | Cost-effectiveness analysis of pandemic influenza preparedness: what's missing? |
| 000696 | Tara A. Lavelle [Maroc, États-Unis] ; Timothy M. Uyeki [États-Unis] ; Lisa A. Prosser [États-Unis] | Cost-Effectiveness of Oseltamivir Treatment for Children with Uncomplicated Seasonal Influenza |
| 001305 | Praveen Dhankhar [États-Unis] ; John D. Grabenstein [États-Unis] ; Megan A. O'Brien [États-Unis] ; Erik J. Dasbach [États-Unis] | Cost-Effectiveness of Stockpiling 23-Valent Pneumococcal Polysaccharide Vaccine to Prevent Secondary Pneumococcal Infections Among a High-Risk Population in the United States During an Influenza Pandemic |
| 001686 | Nayer Khazeni [États-Unis] ; David W. Hutton ; Alan M. Garber ; Nathaniel Hupert ; Douglas K. Owens | Effectiveness and Cost-Effectiveness of Vaccination Against Pandemic Influenza (H1N1) 2009 |
| 001A47 | Maarten J. Postma [Pays-Bas] ; Annoesjka Novak [Pays-Bas] ; Huib W. K. F. H. Scheijbeler [Pays-Bas, Royaume-Uni] ; Marlene Gyldmark [Suisse] ; Marianne L. L. Van Genugten [Pays-Bas] ; Jan C. Wilschut [Pays-Bas] | Cost effectiveness of oseltamivir treatment for patients with influenza-like illness who are at increased risk for serious complications of influenza : Illustration for the netherlands |
| 001B51 | Beate Sander [Canada] ; Frederick G. Hayden [États-Unis] ; Marlene Gyldmark [Suisse] ; Louis P. Jr Garrison [Suisse] | Post-exposure influenza prophylaxis with oseltamivir: cost effectiveness and cost utility in families in the UK |
| 001E64 | La grippe. Stratégies de vaccination. |
| This area was generated with Dilib version V0.6.34. |  |